Shares of BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report) reached a new 52-week high on Tuesday . The stock traded as high as $2.05 and last traded at $1.92, with a volume of 58127 shares traded. The stock had previously closed at $1.98.
BioRestorative Therapies Trading Down 2.6 %
The stock has a market cap of $3.07 billion, a P/E ratio of -1.75 and a beta of 102.36. The firm has a 50-day simple moving average of $1.51 and a two-hundred day simple moving average of $1.53.
About BioRestorative Therapies
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Featured Stories
- Five stocks we like better than BioRestorative Therapies
- The Significance of Brokerage Rankings in Stock Selection
- Celebrate July 4th with These Red, White, & Blue Chip Stocks
- Business Services Stocks Investing
- AbbVie Stock: A Perfect Dip for Investors to Buy
- How to Calculate Stock Profit
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
